Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I

Structure

Volumn 7, Issue 4, 1999, Pages 391-398

  Maenaka, Katsumi ^a,b,c,d   Juji, Takeo ^b   Stuart, David I ^a,e   Jones, E Yvonne ^a,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Crystal structure; Immunoglobulin superfamily; Killer cell inhibitory receptor; Major histocompatibility complex (MHC) class I binding; Natural killer cell

Indexed keywords

HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; IMMUNOREGULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; STRUCTURE ANALYSIS; T LYMPHOCYTE;

EID: 0242500174     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(99)80052-5     Document Type: Article

References (42)

1. Lanier, L.L. (1997). Natural killer cells: From no receptors to too many. Immunity 6, 371-378.
2. Lanier, L.L. (1998). NK cell receptors. Annu. Rev. Immunol, 16, 359-393.
3. Long, E.O. (1998). Regulation of immune responses by inhibitory receptors. Adv. Exp. Med. Biol. 452, 19-28.
4. Colonna, M. & Samaridis, J. (1995). Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268, 405-408.
5. Wagtmann, N., et al., amp; Long, E.O., (1995). Molecular clones of the p58 natural killer cell receptor reveal lg-related molecules with diversity in both the extra and intracellular Domains. Immunity 2, 439-449.
6. D'Andrea, A., Chang, C., Franz-Bacon, K., McClanahan, T., Philips, J.H. & Lanier, L.L. (1995). Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J. Immunol. 155, 2306-2310.
7. Steffens, U., Selvakumar, A. & Dupont, B. (1998). Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR). Tissue Antigens 51, 398-413.
8. Mandelboim, O., et al., & Strominger, J.L. (1996). Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184, 913-922.
9. Mandelboim, O., et al., & Strominger, J.L. (1997). The binding site of NK receptors on HLA-C molecules. Immunity 6, 341-350.
10. Rajagopalan, S., & Long, E.O. (1997). The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185, 1523-1528.
11. Kim, J., Chwae, Y.J., Kim, M.Y., Choi, I.H., Park, J.H., & Kim, S.J. (1997). Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. J. Immunol. 159, 3875-3882.
12. Winter, C.C., & Long, E.O. (1997). A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J. Immunol. 158, 4026-4028.
13. Biassoni, R., et al. & Moretta, A. (1997). Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur. J. Immunol. 27, 3095-3099.
14. Winter, C.C., Gumperz, J.E., Parham, P., Long, E.O., & Wagtmann, N. (1998). Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 161, 571-577.
15. Vales-Gomez, M., Reyburn, H.T., Erskine, R.A., & Strominger, J.L. (1998). Direct binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc. Natl Acad. Sci. USA 95, 14326-14331.
16. Fan, Q.R., Mosyak, L., Winter, C.C., Wagtmann, N., Long, E.O., & Wiley, D.C. (1996). Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc. Natl Acad. Sci. USA 93, 7178-7183.
17. Fan, Q.R., Mosyak, L., Winter, C.C., Wagtmann, N., Long, E.O., & Wiley, D.C. (1997). Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature 389, 96-100.
18. Holm, L., & Sander, C. (1993). Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233, 123-138.
19. Casasnovas, J.M., Springer, T.A., Liu, J.H., Harrison, S.C., & Wang, J.H. (1997). Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature 387, 312-315.
20. Jones, E.Y., et al., & Stuart, D.I. (1995). Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 Å resolution. Nature 373, 539-544.
21. Chothia, C., & Jones, E.Y. (1997). The molecular structure of cell adhesion molecules. Annu. Rev. Biochem. 66, 823-862.
22. de Vos A.M., Ultsch, M.H. & Kossiakoff, A.A. (1992). Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255, 306-12.
23. Bork, P., & Doolittle, R.F. (1992). Proposed acquisition of an animal protein domain by bacteria. Proc. Natl Acad. Sci. USA. 89, 8990-8994.
24. Livnah, O. Stura, E.A., Johnson, D.L., Middleton, S.A., Mulcahy, L.S., Wrighton, N.C., Dower, W.J., Jolliffe, L.K., & Wilson, I.A. (1996). Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 Å. Science 273, 464-471.
25. Somers, W., Ultsch, M.H., de Vos A.M., & Kossiakoff, A.A. (1994). The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372, 478-481.
26. Bravo, J., Stauton, D., Heath, J.K., & Jones, E.Y. (1998). Crystal structure of a cytokine-binding region of gp130. EMBO J. 17, 1665-74.
27. Jones, E.Y., Davis, S.J., Williams, A.F., Harlos, K., & Stuart, D.I. (1995). Crystal structure at 2.8 Å resolution of a soluble form of the cell adhesion molecule CD2. Nature 373, 539-544.
28. Ryu, S.E., et al., & Hendrickson, W.A. (1990). Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 348, 419-426.
29. Wang, J.H., et al., & Harrison, S.C. (1990). Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348, 411-418.
30. Muller, Y.A., Kelley, R.F. & de Vos A.M. (1998). Hinge bending within the cytokine receptor superfamily revealed by the 2.4 Å crystal structure of the extracellular domain of rabbit tissue factor. Protein Sci. 7, 1106-1115.
31. Clackson, T., & Wells, J.A. (1995). A hot spot of binding energy in a hormone-receptor interface. Science 267, 383-386.
32. Maenaka, K., Juji, T., Tadokoro, K., Harlos, K., Stuart, D.I., & Jones, E.Y. (1998). Crystallisation and preliminary diffraction studies of the extracellular region of human p58 killer cell inhibitory complex (KIR2). Acta Crystallogr. D 54, 433-435.
33. Harlos, K. (1992). Micro-bridges for sitting drop crystallization. J. Appl. Cryst. 25, 536-538.
34. Sakabe, N. (1991). X-ray diffraction data collection system for modern protein crystallography with a Weissenberg camera and an imaging plate using synchrotron radiation. Nucl. Instrum. Methods Phys. Res. A 303, 448-463.
35. Otwinowski, Z., & Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Meth. Enzymol. 276, 307-326.
36. Tong, L. (1996). Combined molecular replacement. Acta Crystallogr. A 52, 782-784.
37. Brünger, A.T. (1992). X-PLOR Version 3.1: A System for X-ray Crystallography and NMR. Yale University Press, New Haven, CT, USA.
38. Collaborative Computational Project No.4 (1994). The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D 50, 760-763.
39. Brünger, A.T., et al., & Warren, G.L. (1998). Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921.
40. Jones, T.A., Zou, J.Y., Cowan, S.W., & Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119.
41. Esnouf, R.M. (1997). An extensively modified version of molscript which includes greatly enhanced colouring capabilities. J. Mol. Graph. 15, 133-138.
42. Merritt, E.A., & Murphy, M.E.P. (1994). Raster3D version 2.0. A program for photorealistic molecular graphics. Acta Cryst. D 50, 869-873.